¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Blue Cross Association research series."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blue to green
    û³ì»ö
  • Evans blue
    ¿¡¹ø½ººí·ç
  • methylene blue
    ¸ÞÆ¿·»ºí·ç
  • prussian blue reaction
    °¨Ã»¹ÝÀÀ
  • association
    1. ¿¬ÇÕ 2. ¿¬»ó 3. ¿¬°ü
  • association area
    ¿¬ÇÕ±¸¿ª
  • association center
    ¿¬ÇÕÁßÃß
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • association cortex
    ¿¬ÇÕ°ÑÁú, ¿¬ÇÕÇÇÁú
  • association disturbance
    ¿¬»óÀå¾Ö
  • association fiber
    ¿¬ÇÕ¼¶À¯
  • association mechanism
    ¿¬ÇÕ±âÀü
  • association neuron
    ¿¬ÇսŰ漼Æ÷
  • association neurosis
    ¿¬ÇսŰæÁõ
  • association paralysis
    ¿¬ÇÕ¸¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blue nevus
    û»ö¸ð¹Ý
  • blue pus
    û»ö°í¸§
  • blue sclera
    û»ö°ø¸·
  • blue tumor
    û»öÁ¾
  • methylene blue
    ¸ÞÆ¿·»ºí·ç
  • toluidine blue
    Åç·çÀ̵òºí·ç
  • prussian blue reaction
    °¨Ã»¹ÝÀÀ
  • association
    ¿¬ÇÕ, ¿¬»ó, ¿¬°ü
  • association center
    ¿¬ÇÕÁßÃß
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • association cortex
    ¿¬ÇÕ°ÑÁú, ¿¬ÇÕÇÇÁú
  • association disturbance
    ¿¬»óÀå¾Ö
  • association fiber
    ¿¬ÇÕ¼¶À¯
  • association mechanism
    ¿¬ÇÕ±âÀü
  • association neuron
    ¿¬ÇսŰ漼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Cross-Bevan reagent
    Å©·Î½º-º£¹Ý½Ã¾à.
  • Jackson cross cylinder
    Àè½¼±³Â÷¿øÁÖ(·»Áî)
  • absorption, cross
    ±³Â÷Èí¼ö½ÃÇè
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antigen, cross-reacting
    ±³Â÷¹ÝÀÀÇ׿ø
  • genus cross
    ¼Ó°£±³¹è(áÕÊàÎßÛÕ).
  • immunity, cross
    ±³Â÷¸é¿ª
  • incision, cross hatching
    ±³Â÷Àý°³(¼ú)
  • plasma cross matching
    Ç÷Àå±³Â÷½ÃÇè(úìíìÎßó©ãËúÐ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • trigonometric series
    »ï°¢±Þ¼ö(¡­Ðäâ¦).
  • upper gastrointestinal series
    »óºÎÀ§Àå°üÁ¶¿µ¼ú
  • american association of physicists in medicine (AA
    PM) ¹Ì±¹ÀÇÇй°¸®ÇÐȸ
  • association
    ¿¬ÇÕ(æáùê), ¿¬»ó(æáßÌ).
  • association
    ¿¬»ó(æáßÌ)
  • association area
    ¿¬ÇÕ ¿µ¿ª(æáùêçÐæ´)
  • association center
    ¿¬ÇÕÁßÃß(¡­ñéõÒ)
  • association constant
    ¿¬ÇÕ»ó¼ö(æáùêßÈâ¦).
  • association cortex
    ¿¬ÇÕÇÇÁú(¡­ù«òõ).
  • association disease
    ¿¬»óº´
  • association disturbance
    ¿¬»óÀåÇØ
  • association disturbance
    ¿¬»óÀå¾Ö.
  • association experiment
    ¿¬»ó½ÇÇè
  • association fiber
    ¿¬ÇÕ¼¶À¯(¡­àéë«)
  • association fibers
    ¿¬ÇÕ¼¶À¯
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-bridge
    ±³Â÷±³(Îßó©Îé)
  • cross-¥â-conformation
    ±³Â÷-¥â-ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • cross-electrophoresis
    ±³Â÷Àü±â¿µµ¿(Îßó©ï³Ñ¨ç¶ÔÑ)
  • cross-hybridization
    ±³Â÷(Îßó©)Æ¢±â Çü¼º(û¡à÷)
  • cross-induction
    ±³Â÷À¯µµ(Îßó©ë¯Óô)
  • cross-infection
    ±³Â÷°¨¿°(Îßó©Êïæø)
  • cross-linker
    ±³Â÷¿¬°èÀÚ(Îßó©ææÍ¨í­)
  • cross-linking
    ±³Â÷¿¬°è(Îßó©ææÍ¨)
  • cross-matching
    ±³Â÷ÀûÇÕ°Ë»ç(Îßó©îêùêËþÞÛ)
  • cross-partition
    ±³Â÷ºÐ¹è(Îßó©ÝÂÛÕ)
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀ Ç×ü(Îßó©Úãëëù÷ô÷)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BT base of tongue; bedtime; bitemporal; bitrochanteric; bladder tumor; Blalock-Taussig [shunt]; bleedin...
CB Bachelor of Surgery [Lat. Chirurgiae Baccalaureus]; calcium blocker; carbenicillin; carotid body; ch...
TB Taussig-Bind [syndrome]; terabyte; term birth; terminal bronchiole; terminal bronchus; thromboxane B...
BSA benzenesulfonic acid; Biofeedback Society of America; bismuth-sulfite agar; bis-trimethylsilyl-aceta...
ADA adenosine deaminase; American Dental Association; American Dermatological Association; American Diab...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CRM Cross-reacting material
CRI Cross-reactive idiotypes
X-SA Cross-sectional area
CSMI Cross-sectional moment of inertia
DCLHb Diaspirin Cross-Linked Hemoglobin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blue superficially situated bulging lesion
    õÃþ û»ö À¶±â º´¼Ò
  • blue-black change
    Ã»Èæ º¯È­
  • blue-brown discoloration
    °¥Ã» º¯»ö
  • blue-red center
    Àûû»ö Á᫐ ºÎÀ§
  • blue-yellow blindness
    û-Ȳ »ö¸Í
    û»ö°ú Ȳ»öÀÇ Áö°¢ ½Äº°ÀÌ ºÒ¿ÏÀüÇÑ °Í.
  • Borrel's blue
    º¸·¼Ã»
    ½ºÇÇ·ÎŰŸ ¿°»ö¿¡ ¾²´Â »êÈ­Àº ¿°·á.
  • bromchlorphenol blue
    ºê·Ò Ŭ·Î¸£Æä³î û
    Áö½Ã¾à.
  • bromothymol blue
    ºê·Î¸ðŸÀ̸ô û
    BTB. ¿°·á. ¼ö¼Ò À̿ ³óµµÀÇ Áö½Ã¾àÀ¸·Î ¾²À̰í,
  • cellular blue nevus
    ¼¼Æ÷¼º û»ö ¸ð¹Ý
    û»ö ¸ð¹ÝÀÇ Æ¯ÀÌÇÑ º¯ÇüÀ¸·Î¼­ ÀÓ»óÀû ¹× Á¶Á÷ÇÐÀûÀ¸·Î ¾Ç¼º Èæ»öÁ¾À¸·Î ¿ÀÀεDZ⠽±´Ù. À̰ÍÀº µÐºÎ¿Í õ¹Ì°ñ ºÎÀ§¿¡ È£¹ßÇϸç Ä¿´Ù¶õ û»ö ¶Ç´Â Èæ»öÀÇ ´Ü´ÜÇÑ °áÀý·Î ³ªÅ¸³­´Ù.
  • dark blue pinhead
    ¾Ïû»öÀÇ ÇÉ ¸Ó¸®
  • dark blue-red
    ¾ÏûÀû»ö
  • eosin methylene blue
    ¿¡¿À½Å ¸ÞÆ¿·» ºí·ç
  • methylene blue
    ¸ÞÆ¿·» ºí·ç¿ì
  • red-blue tumor
    Àûû»ö Á¾¾ç
  • reddish to blue
    Àû»ö¿¡¼­ û»ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nursing administration research research concerned with establishing costs of nursing care, examining the relationships between nursing services and quality patient care, and viewing problems of nursing service delivery within the broader context of policy analysis and delivery of health services
(12 Dec 1998)
nursing education research Investigations into the problems of integrating research findings into nursing curricula, developing problem solving skills, finding approaches to clinical teaching, determining the level of practice by graduates from different basic preparations, etc.
(12 Dec 1998)
nursing evaluation research Research carried out by nurses that uses interviews, data collection, observation, surveys, etc., to evaluate nursing, health, clinical, and nursing education programs and curricula, and which also demonstrates the value of such evaluation.
(12 Dec 1998)
nursing methodology research Research carried out by nurses concerning techniques and methods to implement projects and to document information, including methods of interviewing patients, collecting data, and forming inferences. The concept includes exploration of methodological issues such as human subjectivity and human experience.
(12 Dec 1998)
nursing research Research carried out by nurses, generally in clinical settings, in the areas of clinical practice, evaluation, nursing education, nursing administration, and methodology.
(12 Dec 1998)
dental research The study of laws, theories, and hypotheses through a systematic examination of pertinent facts and their interpretation in the field of dentistry.
(12 Dec 1998)
operations research A group of techniques developed to apply scientific methods and tools to solve the problems of decision making in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting goals and makes use of mathematical models from which solutions for actual problems may be derived.
(12 Dec 1998)
epidemiologic research design The form and structure of analytic studies in epidemiologic and clinical research.
(12 Dec 1998)
united states agency for health care policy and research An agency of the public health service established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery.." it supersedes the national centre for health services research.
(12 Dec 1998)
united states office of research integrity An office of the united states public health service organised in june 1992 to promote research integrity and investigate misconduct in research supported by the public health service. It consolidates the office of scientific integrity of the national institutes of health and the office of scientific integrity review in the office of the assistant secretary for health. The ori is in the office of the assistant secretary for health and its director reports directly to the assistant secretary for health, department of health and human services. (ri newsletter, 1993 jan; 1(1):1)
(12 Dec 1998)
american dental association Professional society representing the field of dentistry.
(12 Dec 1998)
american heart association A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.
(12 Dec 1998)
american hospital association A professional society in the united states whose membership is composed of hospitals.
(12 Dec 1998)
american medical association Professional society representing the field of medicine.
(12 Dec 1998)
american nurses' association Professional society representing the field of nursing.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • motivational research
    µ¿±â Á¶»ç
  • operations research
    ±â¾÷ °æ¿µ»óÀÇ °úÇÐÀû Á¶»ç ¿¬±¸;ÀÛÀü ¿¬±¸
  • research
    (Çмú)¿¬±¸;°úÇÐÀû ޱ¸;ÇмúÁ¶»ç;(½ÅÁßÇÑ)¼ö»ö;ޱ¸;Á¶»ç;¿¬±¸ ´É·Â;¿¬±¸½É;¿¬±¸ÇÏ´Ù;Á¶»çÇÏ´Ù;~able
  • research and development
    ¿¬±¸¿Í °³¹ß
  • research laboratory(institute)
    ¿¬±¸¼Ò
  • research library
    ¿¬±¸ µµ¼­°ü ´Â
  • research paper
    ¿¬±¸ ³í¹®;(ÇлýÀÇ)Çб⸻ ¸®Æ÷Æ®
  • research professor
    ¿¬±¸ ±³¼ö(´ëÇÐ µî¿¡¼­ ÀÚÀ¯·ÎÀÌ ¿¬±¸¿¡ ¸ôµÎÇÒ ¼ö ÀÖ´Â ±³¼ö)
  • research reactor
    ¿¬±¸¿ë ¿øÀÚ·Î
  • research submersible
    ½ÉÇØ Àá¼ö Á¶»ç¼±
  • research work
    (Çмú»óÀÇ)¿¬±¸;Á¶»ç
  • research worker
    =RESEARCHER
  • blue
    Ǫ¸¥,¿ì¿ïÇÑ,ÆÄ¶û,¿ì¿ïÁõ
  • blue-black
    ¾Ïû»öÀÇ
  • blue-pencil
    ÆíÁýÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á